| Original language | English |
|---|---|
| Pages (from-to) | 945-947 |
| Number of pages | 3 |
| Journal | Annals of the Rheumatic Diseases |
| Volume | 73 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published - 2014 |
Fingerprint
ASJC Scopus subject areas
- Rheumatology
- Immunology
- Biochemistry, Genetics and Molecular Biology(all)
- Immunology and Allergy
Cite this
Baseline levels of soluble interleukin-6 receptor predict clinical remission in patients with rheumatoid arthritis treated with tocilizumab : Implications for molecular targeted therapy. / Nishina, Naoshi; Kikuchi, Jun; Hashizume, Misato; Yoshimoto, Keiko; Kameda, Hideto; Takeuchi, Tsutomu.
In: Annals of the Rheumatic Diseases, Vol. 73, No. 5, 2014, p. 945-947.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Baseline levels of soluble interleukin-6 receptor predict clinical remission in patients with rheumatoid arthritis treated with tocilizumab
T2 - Implications for molecular targeted therapy
AU - Nishina, Naoshi
AU - Kikuchi, Jun
AU - Hashizume, Misato
AU - Yoshimoto, Keiko
AU - Kameda, Hideto
AU - Takeuchi, Tsutomu
PY - 2014
Y1 - 2014
UR - http://www.scopus.com/inward/record.url?scp=84898003691&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84898003691&partnerID=8YFLogxK
U2 - 10.1136/annrheumdis-2013-204137
DO - 10.1136/annrheumdis-2013-204137
M3 - Article
C2 - 24336338
AN - SCOPUS:84898003691
VL - 73
SP - 945
EP - 947
JO - Annals of the Rheumatic Diseases
JF - Annals of the Rheumatic Diseases
SN - 0003-4967
IS - 5
ER -